Vaccine effectiveness of ChAdOx1 nCoV-19 against COVID-19 in a socially vulnerable community in Rio de Janeiro, Brazil: author's response.

Ranzani, Otavio T; Bozza, Fernando A

Ranzani, Otavio T; Bozza, Fernando A.

Ranzani OT; Barcelona Institute for Global Health, ISGlobal, Universitat Pompeu Fabra, CIBER Epidemiología y Salud Pública, Barcelona, Spain; Pulmonary Division, Heart Institute (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Brazil. Electronic address: otavio.ranzani@isglobal.org.
Bozza FA; National Institute of Infectious Disease Evandro Chagas, Oswaldo Cruz Foundation (INI-FIOCRUZ), Rio de Janeiro, Brazil; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil. Electronic address: fernando.bozza@ini.fiocruz.br.

Clin Microbiol Infect ; 28(8): 1166-1167, 2022 08.

Article in English | MEDLINE | ID: covidwho-1859447

Subject(s)

COVID-19; Brazil/epidemiology; COVID-19/prevention & control; ChAdOx1 nCoV-19; Humans; Vaccine Efficacy

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Experimental Studies / Observational study Topics: Vaccines Limits: Humans Country/Region as subject: South America / Brazil Language: English Journal: Clin Microbiol Infect Journal subject: Communicable Diseases / Microbiology Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google